Submitted:
30 September 2024
Posted:
03 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results
2.1. Detection and Isolation of Phage from C. difficile Strain 500/12
2.2. The Phage phiCDKH02 Induced from 500/12 Strain is Identical to phi027 Bacteriophage
2.3. Identification of phi027 Prophage in Clinical Isolates
2.4. The phi027 Prophage Is Present in Other Hypervirulent Strains of C. difficile
2.5. The phi027 Bacteriophage Influences the Host’s Properties
3. Discussion
4. Materials and Methods
4.1. Bacterial Strains and Growth Conditions
4.2. Cell Cultures
4.3. Prophage Induction and Phage Isolation
4.4. Phage Genome Sequencing and Annotation
4.5. Whole-Genome Sequencing of Clinical Isolates
4.6. Identification of phiCDKH02 Homologs
4.7. Analysis of Sequenced Genomes
4.8. In Silico Ribotyping of phi027 Lysogens
4.9. Building a Maximum Likelihood Tree of phi027 Lysogens
| Protein_id | Product |
|---|---|
| AJP10080.1 | putative cell surface protein |
| AJP13166.1 | putative cell surface protein |
| AJP10067.1 | putative membrane protein |
| AJP10068.1 | putative ATPase |
| AJP13155.1 | putative ATPase |
| AJP13154.1 | putative conjugative transposon protein |
4.10. Plasmids Construction
4.11. Conjugation of C. difficile and Mutant Screening
4.12. Plasmids Curing
4.13. Testing the Ability of C. difficile to Produce Biofilm In Vitro
4.14. Analysis of C. difficile Spore Formation
4.15. Adhesion of C. difficile Strains to Human Epithelial Cell Lines
4.16. Cytotoxicity Assays
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Miller, B.A.; Chen, L.F.; Sexton, D.J.; Anderson, D.J. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect. Control Hosp. Epidemiol. 2011, 32, 387–390. [Google Scholar] [CrossRef]
- Leffler, D.A.; Lamont, J.T. Clostridium difficile infection. N. Engl. J. Med. 2015, 372, 1539–1548. [Google Scholar] [CrossRef]
- Pumiglia, L.; Wilson, L.; Rashidi, L. Clostridioides difficile Colitis. Surg. Clin. North. Am. 2024, 104, 545–556. [Google Scholar] [CrossRef]
- Aktories, K.; Schwan, C.; Jank, T. Clostridium difficile Toxin Biology. Annu. Rev. Microbiol. 2017, 71, 281–307. [Google Scholar] [CrossRef]
- Gerding, D.N.; Johnson, S.; Rupnik, M.; Aktories, K. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut. Microbes. 2014, 5, 15–27. [Google Scholar] [CrossRef]
- Merrigan, M.; Venugopal, A.; Mallozzi, M.; Roxas, B.; Viswanathan, V.K.; Johnson, S.; Gerding, D.N.; Vedantam, G. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J. Bacteriol. 2010, 192, 4904–4911. [Google Scholar] [CrossRef]
- Drudy, D.; Quinn, T.; O’Mahony, R.; Kyne, L.; O’Gaora, P.; Fanning, S. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. J. Antimicrob. Chemother. 2006, 58, 1264–1267. [Google Scholar] [CrossRef]
- Indra, A.; Huhulescu, S.; Schneeweis, M.; Hasenberger, P.; Kernbichler, S.; Fiedler, A.; Wewalka, G.; Allerberger, F.; Kuijper, E.J. Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J. Med. Microbiol. 2008, 57, 1377–1382. [Google Scholar] [CrossRef]
- Warny, M.; Pepin, J.; Fang, A.; Killgore, G.; Thompson, A.; Brazier, J.; Frost, E.; McDonald, L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366, 1079–1084. [Google Scholar] [CrossRef]
- Goorhuis, A.; Bakker, D.; Corver, J.; Debast, S.B.; Harmanus, C.; Notermans, D.W.; Bergwerff, A.A.; Dekker, F.W.; Kuijper, E.J. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 2008, 47, 1162–1170. [Google Scholar] [CrossRef]
- Heuler, J.; Fortier, L.C.; Sun, X. Clostridioides difficile phage biology and application. FEMS Microbiol. Rev. 2021, 45, fuab012. [Google Scholar] [CrossRef] [PubMed]
- Meessen-Pinard, M.; Sekulovic, O.; Fortier, L.C. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl. Environ. Microbiol. 2012, 78, 7662–7670. [Google Scholar] [CrossRef] [PubMed]
- Howard-Varona, C.; Hargreaves, K.R.; Abedon, S.T.; Sullivan, M.B. Lysogeny in nature: mechanisms, impact and ecology of temperate phages. ISME J. 2017, 11, 1511–1520. [Google Scholar] [CrossRef] [PubMed]
- Govind, R.; Vediyappan, G.; Rolfe, R.D.; Dupuy, B.; Fralick, J.A. Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J. Virol. 2009, 83, 12037–12045. [Google Scholar] [CrossRef]
- Revathi, G.; Fralick, J.A.; Rolfe, R.D. In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119. Anaerobe 2011, 17, 125–129. [Google Scholar] [CrossRef]
- Meader, E.; Mayer, M.J.; Gasson, M.J.; Steverding, D.; Carding, S.R.; Narbad, A. Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system. Anaerobe 2010, 16, 549–554. [Google Scholar] [CrossRef]
- Sekulovic, O.; Meessen-Pinard, M.; Fortier, L.C. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J. Bacteriol. 2011, 193, 2726–2734. [Google Scholar] [CrossRef]
- Goh, S.; Chang, B.J.; Riley, T.V. Effect of phage infection on toxin production by Clostridium difficile. J. Med. Microbiol. 2005, 54, 129–135. [Google Scholar] [CrossRef]
- Sekulovic, O.; Fortier, L.C. Global transcriptional response of Clostridium difficile carrying the CD38 prophage. Appl. Environ. Microbiol. 2015, 81, 1364–1374. [Google Scholar] [CrossRef]
- Hargreaves, K.R.; Kropinski, A.M.; Clokie, M.R. What does the talking?: quorum sensing signalling genes discovered in a bacteriophage genome. PLoS One. 2014, 24, e85131. [Google Scholar] [CrossRef]
- Goh, S.; Hussain, H.; Chang, B.J.; Emmett, W.; Riley, T.V.; Mullany, P. Phage ϕC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. mBio 2013, 4, e00840–13. [Google Scholar] [CrossRef] [PubMed]
- Pituch, H.; Obuch-Woszczatyński, P.; Lachowicz, D.; Wultańska, D.; Karpiński, P.; Młynarczyk, G.; van Dorp, S.M.; Kuijper, E.J. Polish Clostridium difficile Study Group. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Euro Surveill. 2015, 20, 30025. [Google Scholar] [CrossRef] [PubMed]
- Stabler, R.A.; He, M.; Dawson, L.; Martin, M.; Valiente, E.; Corton, C.; Lawley, T.D.; Sebaihia, M.; Quail, M.A.; Rose, G.; Gerding, D.N.; Gibert, M.; Popoff, M.R.; Parkhill, J.; Dougan, G.; Wren, B.W. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 2009, 10, R102. [Google Scholar] [CrossRef] [PubMed]
- Hussain, H.; Nubgan, A.; Rodríguez, C.; Imwattana, K.; Knight, D.R.; Parthala, V.; Mullany, P.; Goh, S. Removal of mobile genetic elements from the genome of Clostridioides difficile and the implications for the organism’s biology. Front. Microbiol. 2024, 20, 1416665. [Google Scholar] [CrossRef] [PubMed]
- Hong, W.; Zhang, J.; Cui, G.; Wang, L.; Wang, Y. Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection. ACS Synth. Biol. 2018, 15, 1588–1600. [Google Scholar] [CrossRef]
- Crobach, M.J.T.; Vernon, J.J.; Loo, V.G.; Kong, L.Y.; Péchiné, S.; Wilcox, M.H.; Kuijper, E.J. Understanding Clostridium difficile Colonization. Clin. Microbiol. Rev. 2018, 14, e00021-e00017. [Google Scholar] [CrossRef]
- Naureen, Z.; Dautaj, A.; Anpilogov, K.; Camilleri, G.; Dhuli, K.; Tanzi, B.; Maltese, P.E.; Cristofoli, F.; De Antoni, L.; Beccari, T.; Dundar, M.; Bertelli, M. Bacteriophages presence in nature and their role in the natural selection of bacterial populations. Acta Biomed. 2020, 91, e2020024. [Google Scholar]
- Wagner, P.L.; Waldor, M.K. Bacteriophage control of bacterial virulence. Infect. Immun. 2002, 70, 3985–3993. [Google Scholar] [CrossRef]
- Knetsch, C.W.; Terveer, E.M.; Lauber, C.; Gorbalenya, A.E.; Harmanus, C.; Kuijper, E.J.; Corver, J.; van Leeuwen, H.C. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect. Genet. Evol. 2012, 12, 1577–1585. [Google Scholar] [CrossRef]
- Dresler, J.; Krutova, M.; Fucikova, A.; Klimentova, J.; Hruzova, V.; Duracova, M.; Houdkova, K.; Salovska, B.; Matejkova, J.; Hubalek, M.; Pajer, P.; Pisa, L.; Nyc, O. Analysis of proteomes released from in vitro cultured eight Clostridium difficile PCR ribotypes revealed specific expression in PCR ribotypes 027 and 176 confirming their genetic relatedness and clinical importance at the proteomic level. Gut Pathog. 2017, 9, 45. [Google Scholar] [CrossRef]
- Edwards, A.N.; Karim, S.T.; Pascual, R.A.; Jowhar, L.M.; Anderson, S.E.; McBride, S.M. Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells. Front. Microbiol. 2016, 7, 1698. [Google Scholar] [CrossRef] [PubMed]
- Ali, S.; Moore, G.; Wilson, A.P. Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants. J. Hosp. Infect. 2011, 79, 97–98. [Google Scholar] [CrossRef] [PubMed]
- Denève, C.; Janoir, C.; Poilane, I.; Fantinato, C.; Collignon, A. New trends in Clostridium difficile virulence and pathogenesis. Int. J. Antimicrob. Agents. 2009, 33, S24–S28. [Google Scholar] [CrossRef] [PubMed]
- Vedantam, G.; Clark, A.; Chu, M.; McQuade, R.; Mallozzi, M.; Viswanathan, V.K. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 2012, 3, 121–134. [Google Scholar] [CrossRef] [PubMed]
- Wultańska, D.; Paterczyk, B.; Nowakowska, J.; Pituch, H. The Effect of selected bee products on adhesion and biofilm of Clostridioides difficile strains belonging to different ribotypes. Molecules 2022, 27, 7385. [Google Scholar] [CrossRef]
- Hinc, K.; Kabała, M.; Iwanicki, A.; Martirosian, G.; Negri, A.; Obuchowski, M. Complete genome sequence of the newly discovered temperate Clostridioides difficile bacteriophage phiCDKH01 of the family Siphoviridae. Arch. Virol. 2021, 166, 2305–2310. [Google Scholar] [CrossRef]
- Darling, A.E.; Mau, B.; Perna, N.T. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 2010, 5, e11147. [Google Scholar] [CrossRef]
- Bidet, P.; Barbut, F.; Lalande, V.; Burghoffer, B.; Petit, J.C. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol. Lett. 1999, 175, 261–266. [Google Scholar] [CrossRef]
- R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available online: https://www.R-project.org/ (accessed on 25 September 2024).
- Camacho, C.; Coulouris, G.; Avagyan, V.; Ma, N.; Papadopoulos, J.; Bealer, K.; Madden, T.L. BLAST+: architecture and applications. BMC Bioinformatics 2009, 10, 421. [Google Scholar] [CrossRef]
- Tamura, K.; Stecher, G.; Kumar, S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 2021, 38, 3022–3027. [Google Scholar] [CrossRef]
- Cartman, S.T.; Kelly, M.L.; Heeg, D.; Heap, J.T.; Minton, N.P. Precise Manipulation of the Clostridium Difficile Chromosome Reveals a Lack of Association between the tcdC Genotype and Toxin Production. Appl. Environ. Microbiol. 2012, 78, 4683–4690. [Google Scholar] [CrossRef] [PubMed]
- Kirk, J.A.; Fagan, R.P. Heat shock increases conjugation efficiency. Clostridium difficile Anaerobe 2016, 42, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Wultańska, D.; Piotrowski, M.; Pituch, H. The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile. Eur. J. Clin. Microbiol. Infect. Dis. 2020, 39, 1391–1399. [Google Scholar] [CrossRef] [PubMed]
- Duncan, C.L.; Strong, D.H. Improved medium for sporulation of Clostridium perfringens. Appl. Microbiol. 1968, 16, 82–89. [Google Scholar] [CrossRef] [PubMed]
- Akerlund, T.; Persson, I.; Unemo, M.; Norén, T.; Svenungsson, B.; Wullt, M.; Burman, L.G. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J. Clin. Microbiol. 2008, 46, 1530–1533. [Google Scholar] [CrossRef]
- Schaeffer, A.B.; Fulton, M.D. A SIMPLIFIED METHOD OF STAINING ENDOSPORES. Science 1933, 77, 194. [Google Scholar] [CrossRef]
- Altamimi, M.; Abdelhay, O.; Rastall, R.A. Effect of oligosaccharides on the adhesion of gut bacteria to human HT-29 cells. Anaerobe 2016, 39, 136–142. [Google Scholar] [CrossRef]
- Settle, C.D.; Wilcox, M.H. Comparison of the Oxoid Clostridium difficile toxin A detection kit with cytotoxin detection by a cytopathic effect method examined at 4, 6, 24 and 48 h, Clin. Microbiol. Infect. 1999, 5, 698–701. [Google Scholar] [CrossRef]








| Strain | HT29 24h 48h |
CCD 841 CoN 24h 48h |
|---|---|---|
| 500/12 | 10-6 10-6 | 10-6 10-6 |
| CKH08 | 10-4 10-5 | 10-4 10-5 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).